Symbol Lookup

Friday December 09, 2016 11:59 PM ET. Data delayed 15 minutes.
0.10 (3.51%)
Open/Prev Close
Day Range
52-Week Range
Vol/Avg Daily Vol
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
Sector Update: Solid Advance for Health Care Stocks
2:02PM ET on Tuesday Nov 29, 2016 by MT Newswires
02:02 PM EST, 11/29/2016 (MT Newswires) -- Top Health Care Stocks JNJ -0.52% PFE +1.01% MRK +0.23% ABT +0.68% AMGN +1.04% Health care stocks were holding big gains, with the NYSE Health Care Index jumping to an 0.8% advance while shares of h...
Midday Update: Bullish Economic Data Mitigates Oil's Sell-Off
12:47PM ET on Tuesday Nov 29, 2016 by MT Newswires
12:47 PM EST, 11/29/2016 (MT Newswires) -- Stocks were clinging to modest gains Tuesday as upbeat economic data was balanced with a significant sell-off in oil futures that has driven the energy sector of the S&P 500 down nearly 2%. Brent crude ...
Sector Update: Health Care
12:41PM ET on Tuesday Nov 29, 2016 by MT Newswires
12:41 PM EST, 11/29/2016 (MT Newswires) -- Health care stocks were holding on to big gains today, with the NYSE Health Care Index jumping out to an 0.8% advance and shares of health care companies in the S&P 500 were also up 0.8% as a group. In c...
Stock Futures Surrender Early Gains on GDP, Falling Oil Prices
9:18AM ET on Tuesday Nov 29, 2016 by MT Newswires
09:18 AM EST, 11/29/2016 (MT Newswires) -- Stock futures were struggling to remain positive after the latest revision to third quarter growth showed an economy growing at a slightly faster pace than anticipated, giving the Federal Reserve plenty ...
CombiMatrix Receives Conditional New York Approval For Pre-Implantation Screening Test To Be Used In IVF
7:33AM ET on Tuesday Nov 29, 2016 by MT Newswires
07:33 AM EST, 11/29/2016 (MT Newswires) -- CombiMatrix (CBMX), a diagnostics company, said its CombiPGS test is for women undergoing in vitro fertilization has received conditional approval from the New York State Department of Health. The test...

Company Information

CombiMatrix Corporation is a provider of molecular diagnostic solutions. The Company specializes in pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis and pediatric developmental disorders, offering deoxyribonucleic acid-based testing for the detection of genetic abnormalities, which cannot be identified through traditional methodologies. It performs genetic testing utilizing a range of cytogenomic techniques, including chromosomal microarray analysis, fluorescence in situ hybridization and karyotyping. Its prenatal and postnatal microarray focuses on diagnosing genomic syndromes associated with intellectual disability, developmental delays, congenital anomalies, dysmorphic features and autism spectrum disorders. It develops and markets its molecular testing services in approximately four markets, such as in vitro fertilization (IVF), miscarriage analysis (products of conception analysis), prenatal genetics and postnatal developmental disorders.


Headquarters310 Goddard Ste 150
IRVINE, CA, United States 92618-4617


Chairman of the BoardRobert Jessup
President, Chief Executive Officer, DirectorMark McDonough
Chief Financial Officer, Treasurer, SecretaryScott Burell
Independent DirectorScott Gottlieb
Independent DirectorRobert Hoffman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$7.1MBeta0.80
Revenue (TTM)$12.0MEPS$-6.92
Shares Out.2.5MBook Value$6.93
Dividend Yield0.00%P/E--
Annual Dividend Rate0.00 USDPrice/Sales (TTM)0.6
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin-42.20%

*GAAP = prior to non-GAAP analyst adjusted earnings.


Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample